Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2021-12-06 00:00:00 ET · period of report 2021-12-02 · accession 0001437749-21-027954 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-06 | 2021-12-02 | PBYI | NOUGUES MAXIMO F | CFO | S - Sale | $2.95 | -162 | 67.3K | -0.2% | -$477.90 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-02 | S | D | 162 | $2.95 | 67,275 | D | — | — |